Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    "nephrogenic diabetes insipidus"
Show Display Options
RSS Create an RSS feed from your search for:
"nephrogenic diabetes insipidus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil;   Drug: calcitonin;   Drug: hydrochlorothiazide/amiloride;   Drug: indomethacin;   Drug: Placebo for sildenafil;   Drug: placebo for calcitonin
2 Completed Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).
Condition: Chronic Heart Failure
Intervention: Drug: Vasopressin V2 Receptor Antagonist
3 Completed Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus, Nephrogenic
Intervention: Drug: chlorothiazide
4 Completed DILIPO (DILutIonal HyPOnatremia)
Condition: Congestive Heart Failure
Intervention: Drug: SR121463B

Indicates status has not been verified in more than two years